GSK EBITDA Growth
GSK plc American Depositary Shares (Each representing two Ordinary Shares) · EBITDA Growth
GSK EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported2.20%period ending
GSK TTM EBITDA YoY % (30.32% → 2.20%)
Year-over-year change
High-resolution chart · PNG
GSK ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 2.2% | |
| 46.5568% | |
| 73.8255% | |
| 61.0945% | |
| 6.5043% | |
| -8.4732% | |
| -26.5881% | |
| -31.4028% | |
| -13.894% | |
| -4.3474% | |
| 3.783% | |
| 20.6994% | |
| 14.1542% | |
| 9.6142% | |
| 18.6316% | |
| -18.0638% | |
| -18.5326% | |
| -29.4446% | |
| -36.0545% | |
| -3.5155% | |
| -3.3049% | |
| 17.6224% | |
| 14.2145% | |
| 3.1636% | |
| 8.1625% | |
| 15.2132% | |
| 36.0061% | |
| 77.0863% | |
| 67.5516% | |
| 43.0131% | |
| 20.1003% | |
| -19.6677% | |
| -4.5229% | |
| 12.6899% | |
| 39.5937% | |
| 114.536% | |
| 109.2926% | |
| 40.9867% | |
| -65.6349% | |
| -76.243% | |
| -78.686% | |
| -73.6462% | |
| 150.0679% | |
| 108.256% | |
| 73.6302% | |
| 68.9356% | |
| -41.4271% | |
| -27.7808% | |
| -10.7842% | |
| -4.4401% | |
| 0.1251% | |
| 8.8443% | |
| -4.2635% | |
| -8% | |
| -11.3911% | |
| 8.4792% | |
| 20.5921% | |
| 61.056% | |
| 75.0485% | |
| -9.2054% | |
| -11.2597% | |
| -43.5462% | |
| -44.6366% | |
| -8.9886% | |
| -4.2775% | |
| 17.1167% | |
| 17.2106% | |
| 4.797% | |
| 23.9063% | |
| 24.3555% | |
| 20.0166% | |
| 31.9716% | |
| -17.4422% | |
| -18.23% | |
| -15.3353% | |
| 204.0404% | |
| 350.5063% | |
| 429.0559% | |
| 647.9615% | |
| -68.2379% | |
| -71.0942% | |
| -75.44% | |
| -82.6214% | |
| 2.411% | |
| -5.6186% | |
| -6.9589% | |
| -8.7069% | |
| -10.9578% | |
| 1.6571% | |
| 7.6936% | |
| 10.8091% | |
| -4.6413% | |
| -8.2425% | |
| -9.8984% | |
| -5.4948% | |
| 22.9843% | |
| 13.0548% | |
| 16.2831% | |
| 6.0252% | |
| 1,751.8321% |